Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 3Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Other solid neoplasm 1Breast 1

Conditions

Multiple Myeloma 1Mesothelioma, Malignant 1Breast Neoplasms 1

Interventions

Cyclophosphamide 1499Cisplatin 1434Paclitaxel 1339Radiotherapy 1310Carboplatin 1266Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 697Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Safety × Clear all
NCT04525859 2025-06-24

Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma

Oncovir, Inc.

Phase 1 Completed
19 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT02065609 2022-10-13

89ZrTrastuzumab Breast Imaging With Positron Emission Tomography

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
52 enrolled 6 charts
Breast

Breast Neoplasms

NCT02786511 2020-01-22

Longterm Follow-up of Subjects Treated With bb2121

Celgene

Completed
50 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡